Impact of COVID-19 on breast cancer screening in the Brazilian Unified Health System (SUS)

1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: investigating the impact of the pandemic on breast cancer screening in the Unified Health System, in addition to comparing the data obtained from other countries. Methods: a quantitative cross-sectional observational study was carried out, with references from the Cancer Information System - SISCAN on the number of mammograms performed from 2014 to 2022 by women in Brazil. Results: data regarding mammography in the high-risk population showed a drop of 38, 39% from 2019 to 2020. While in screening mammography, the decline was slightly more significant, at 39.18% in the same period. Regarding diagnostic mammography, the reduction was 33.15%, and in target population mammography, the peak was in 2019 with 2.721.075. On the other hand, the performance of mammography in patients already treated had a smaller decrease of 9.35%. Conclusions: there was a significant reduction in the number of mammograms performed in 2019 and 2020, which might lead to a late diagnosis of the disease and a worse prognosis.

Cite

CITATION STYLE

APA

Murat, F. A. R., Faria, N. M., Gonçalves, A. C. T., Razera, A. P. R., & Razera, F. P. M. (2023). Impact of COVID-19 on breast cancer screening in the Brazilian Unified Health System (SUS). Medicina (Brazil), 56(1). https://doi.org/10.11606/ISSN.2176-7262.RMRP.2023.201567

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free